Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FiberCell Systems supplies laboratory-scale hollow fiber bioreactors that enable high-density cell culture and co-cultivation under in vivo-like conditions. Their systems are used for applications such as the production of extracellular vesicles, monoclonal antibodies, recombinant proteins, and infectious disease modeling. The company’s products are widely adopted in research institutions and have been used by NASA for space-based cell culture experiments.
No clinical results apply as the company does not develop therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FiberCell Systems.